Launch week offerEnds in00h00m00s

Brett Trost

Scientist

Hospital for Sick Children
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

The genetic correlates of extreme impulsive violence are poorly understood, and there have been few studies that have characterized a large group of affected individuals both clinically and genetically. We performed whole exome sequencing (WES) in 290 males with the life‐course‐persistent, extremely impulsively violent form of antisocial personality disorder (APD) and analyzed the spectrum of rare protein‐truncating variants (rPTVs). Comparisons were made with 314 male controls and publicly available genotype data. Functional annotation tools were used for biological interpretation. Participants were significantly more likely to harbor rPTVs in genes that are intolerant to loss‐of‐function variants (odds ratio [OR] 2.06; p < 0.001), specifically expressed in brain (OR 2.80; p = 0.036) and enriched for those involved in neurotransmitter transport and synaptic processes. In 60 individuals (20%), we identified rPTVs that we classified as clinically relevant based on their clinical associations, biological function and gene expression patterns. Of these, 37 individuals harbored rPTVs in 23 genes that are associated with a monogenic neurological disorder, and 23 individuals harbored rPTVs in 20 genes reportedly intolerant to loss‐of‐function variants. The analysis presents evidence in support of a model where presence of either one or several private, functionally relevant mutations contribute significantly to individual risk of life‐course‐persistent APD and reveals multiple individuals who could be affected by clinically unrecognized neuropsychiatric Mendelian disease. Thus, Mendelian diseases and increased rPTV burden may represent important factors for the development of extremely impulsive violent life‐course‐persistent forms of APD irrespective of their clinical presentation.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Daniel Mueller

Physician-in-Chief and Research Chair

University of Toronto

CANADA
View details

Alexandra Lautarescu

King's College London

UNITED KINGDOM
View details

Stanislav Kmoch

-

CZECH REPUBLIC
View details

M. E. Suzanne Lewis

-

CANADA
View details

Neal Sondheimer

Medical Director

Children's Hospital of Eastern Ontario

CANADA
View details

Marla Mendes de Aquino

Research Associate

Hospital for Sick Children

CANADA
View details

David Ross

Professor

University of Alberta

CANADA
View details

Daniel Moreno De Luca

CASA Research Chair, Associate Professor, Principal Investigator of Precision Medicine in Autism (PRISMA) Group

University of Alberta

CANADA
View details

Ryan Yuen

Scientist

Hospital for Sick Children

CANADA
View details

Takahiro Soda

Assistant Professor

University of Florida

UNITED STATES
View details

Ciara J Molloy

Assistant Professor

Trinity College Dublin

IRELAND
View details

Marcello Scala

Researcher

University of Genoa

ITALY
View details

Stelios Georgiades

Associate Professor

McMaster University

CANADA
View details

Stanley Nelson

Professor

David Geffen School of Medicine at UCLA

UNITED STATES
View details

Tony Charman

King’s College London

UNITED KINGDOM
View details